₹ 0.6 Cr
Volume Transacted
(Jan 15, 2025)
5.6 K
Stocks Traded
(Jan 15, 2025)
Last Updated on: Jan 15, 2025
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
14 Jan 2025 | 1009.15 | 1005 | 1017.7 | 981 |
13 Jan 2025 | 1003.05 | 1009.65 | 1020.5 | 996.95 |
10 Jan 2025 | 1008.95 | 1060.9 | 1060.9 | 1003.95 |
09 Jan 2025 | 1054.9 | 1070 | 1070.05 | 1044.05 |
08 Jan 2025 | 1064.85 | 1109.95 | 1109.95 | 1059 |
07 Jan 2025 | 1091.05 | 1042.2 | 1093.25 | 1042.2 |
06 Jan 2025 | 1062.65 | 1053.25 | 1122.4 | 1049.2 |
03 Jan 2025 | 1052.15 | 1051.6 | 1066 | 1043.75 |
02 Jan 2025 | 1050.55 | 1031.05 | 1057.8 | 1031.05 |
01 Jan 2025 | 1048.35 | 1059.95 | 1065.35 | 1042.5 |
Date | Price (₹) |
---|---|
14 Jan 2025 | 1009.15 |
13 Jan 2025 | 1003.05 |
10 Jan 2025 | 1008.95 |
09 Jan 2025 | 1054.9 |
08 Jan 2025 | 1064.85 |
07 Jan 2025 | 1091.05 |
06 Jan 2025 | 1062.65 |
03 Jan 2025 | 1052.15 |
02 Jan 2025 | 1050.55 |
01 Jan 2025 | 1048.35 |
Alembic Pharmaceuticals receives USFDA approval for Brexpiprazole Tablets
Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...
15 Jan 2025 12:54
Alembic Pharma receives USFDA nod for Brexpiprazole tablets
Brexpiprazole is an atypical antipsychotic used as an adjunctive therapy to antidepressant...
15 Jan 2025 14:47
Alembic Pharmaceuticals receives USFDA approval for Divalproex Sodium
Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...
20 Dec 2024 18:30
Alembic Pharma gets USFDA nod for seizure treatment drug
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...
20 Dec 2024 14:20
Alembic Pharma Panelav unit clears Brazil GMP audit
Alembic Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency ...
11 Dec 2024 12:39
Alembic Pharma receives USFDA's tentative approval for Olopatadine Hydrochloride Ophthalmic Solution
Alembic Pharmaceuticals announced that it has received Tentative Approval from the US Food...
04 Dec 2024 16:41
Concalls
Feb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptFeb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptUnlimited trading starting at just Rs. 249*